Position
BRANDYWINE MANAGERS, LLC in Beam Therapeutics Inc.
Back to the book · All holders of BEAM
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$72.4K$27.72 → $23.83
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 18.6K | $515.8K | — | — | — | 0.3% |
| Q1 2026 | 25.5K | $606.6K | $23.83 | −$72.4K | $163.2K | 0.4% |